交易 Bristol Myers BMY

出售
 購買

BristolMyers實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%)： 開倉 高 低

BristolMyers 新聞

盧昕穎 2025 Aug 04, 10:10

經濟訊號混雜：美國經濟正駛入波濤洶湧的水域？

許景桓 2025 Aug 04, 10:10

英國通膨展望：即將到來的利率決策中，意見分歧

盧昕穎 2025 Aug 04, 07:10

OpenAI 以推薦《萬神殿》暗示 GPT-5，引發人工智慧猜測

盧昕穎 2025 Aug 04, 06:10

紅燈亮起：美國經濟瀕臨衰退？

林芷柔 2025 Aug 04, 04:10

美元強勢與股市：分析及潛在風險評估

黃達傑 2025 Jul 30, 16:00

生技股值得關注：EXEL、CRMD、HRMY、ETON、ATRA

黃達傑 2025 Jul 29, 16:00

如何交易比特幣CFD：比特幣價格（BTC/USD）會在2025年達到20萬美元嗎？

黃達傑 2025 Jul 28, 16:00

加密 CFD 交易基礎：比特幣 CFD、以太坊 CFD、索拉納 CFD

黃達傑 2025 Jul 21, 16:00

最佳差價合約（CFD）經紀商：FBS、FP Markets、IC Markets、FxPro、Markets.com

黃達傑 2025 Jul 20, 16:00

XRP 價格飆升：如何在 Markets.com 交易 XRP CFD？

最新新聞

顯示更多
盧昕穎 2025 Aug 04, 09:20

貿易協議後，日本央行升息預期升高

張瑋庭 2025 Aug 04, 02:20

川普的核武言論：僅是轉移焦點還是真正的升級？

林芷柔 2025 Aug 04, 01:20

印度無視川普威脅，持續進口俄羅斯石油：能源安全與地緣政治的權衡

盧昕穎 2025 Aug 04, 01:20

川普對瑞士徵收關稅：經濟衰退擔憂與潛在協議調整

盧昕穎 2025 Aug 02, 00:20

市場回顧：川普關稅、聯準會升息預期與喜憂參半的經濟數據

許景桓 2025 Aug 01, 23:20

市場回顧：川普關稅、聯準會政策、數位資產及其他重要發展

陳昊然 2025 Aug 01, 15:20

OPEC+ 面臨十字路口：增產與未來市場挑戰

盧昕穎 2025 Aug 01, 14:20

美國就業增長放緩：聯準會的影響

聯絡方式

點差

0.28

點差(%)

0.6375 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場開放

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

90027507712

流通股份

2035440000

收益日期（下一個）

2001-08-07

現金殖利率 

2025-08-01

除息日

2025-07-03

遠期年股息率

2.48

遠期年現金殖利率

0.0561

每股盈餘

2.49

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Jul 27, 16:00

如何交易熱門股票CFD：FIX股票、LYEL股票、GNTX股票

黃達傑 2025 Jul 24, 16:00

Deckers 股票今日漲幅驚人：如何交易 DECK 股票 CFD？

黃達傑 2025 Jul 23, 16:00

趨勢股票CFD概述：TSLA CFD、Google CFD、RIVN CFD

Trustpilot